全文获取类型
收费全文 | 6222篇 |
免费 | 357篇 |
国内免费 | 78篇 |
专业分类
耳鼻咽喉 | 96篇 |
儿科学 | 88篇 |
妇产科学 | 107篇 |
基础医学 | 627篇 |
口腔科学 | 193篇 |
临床医学 | 568篇 |
内科学 | 1663篇 |
皮肤病学 | 55篇 |
神经病学 | 679篇 |
特种医学 | 340篇 |
外科学 | 1099篇 |
综合类 | 6篇 |
一般理论 | 1篇 |
预防医学 | 231篇 |
眼科学 | 55篇 |
药学 | 328篇 |
中国医学 | 8篇 |
肿瘤学 | 513篇 |
出版年
2024年 | 14篇 |
2023年 | 104篇 |
2022年 | 189篇 |
2021年 | 307篇 |
2020年 | 221篇 |
2019年 | 240篇 |
2018年 | 261篇 |
2017年 | 168篇 |
2016年 | 232篇 |
2015年 | 254篇 |
2014年 | 293篇 |
2013年 | 378篇 |
2012年 | 531篇 |
2011年 | 524篇 |
2010年 | 286篇 |
2009年 | 257篇 |
2008年 | 335篇 |
2007年 | 341篇 |
2006年 | 284篇 |
2005年 | 263篇 |
2004年 | 259篇 |
2003年 | 224篇 |
2002年 | 166篇 |
2001年 | 49篇 |
2000年 | 30篇 |
1999年 | 34篇 |
1998年 | 42篇 |
1997年 | 34篇 |
1996年 | 25篇 |
1995年 | 20篇 |
1994年 | 18篇 |
1993年 | 16篇 |
1992年 | 29篇 |
1991年 | 20篇 |
1990年 | 21篇 |
1989年 | 14篇 |
1988年 | 20篇 |
1987年 | 14篇 |
1986年 | 15篇 |
1985年 | 14篇 |
1984年 | 19篇 |
1983年 | 9篇 |
1979年 | 12篇 |
1977年 | 6篇 |
1974年 | 4篇 |
1973年 | 12篇 |
1971年 | 6篇 |
1970年 | 5篇 |
1969年 | 5篇 |
1966年 | 4篇 |
排序方式: 共有6657条查询结果,搜索用时 0 毫秒
41.
Antonio Loforte Mariafrancesca Fiorentino Giacomo Murana Gregorio Gliozzi Giulio Giovanni Cavalli Carlo Mariani Sofia Martin Suarez Davide Pacini 《Transplantation proceedings》2021,53(1):311-317
BackgroundThe occurrence of early graft failure (EGF) after heart transplantation (Htx) often requires a mechanical circulatory support (MCS) therapy. The aims of our study were to identify risk factors of mechanically supported severe EGF and evaluate their impact on both early and late outcomes.MethodsBetween January 2000 and December 2019, 499 consecutive adult patients underwent Htx at our institution. Severe EGF was defined as the need for extracorporeal life support (ECLS) within 24 hours after surgery. All available recipient and donor variables were retrospectively analyzed.ResultsOverall, EGF occurred in 58 (11.6%) patients. Post-Htx peripheral or central ECLS was necessary in 32 (6.4%) cases. Independent predictors of severe EGF were, in the recipient group, preoperative transpulmonary gradient (TPG) >12 mm Hg (odds ratio [OR] 4.1, P = .013), preoperative inotropic score >10 (OR 7.3, P = .0001), and pre-Htx ECLS support (OR 5.2, P = .015), while in the donors, a Eurotransplant donor score ≥17 (OR 8.5, P = .005). The absence of EGF was related with a better survival at 1 year and 5 years (94% and 85%, respectively) compared with EGF requiring ECLS population (36% and 28% at 1 year and 5 years, respectively; P < .001). A five-year conditional survival rate did not differ significantly (85% no EGF vs 83% EGF requiring ECLS).ConclusionBoth donor and recipient factors may influence EGF occurrence. Post-Htx ECLS may impact negatively early; however, patients weaned from ECLS eventually benefit from such a rescue treatment with outcomes comparable with Htx patients who did not suffer EGF. 相似文献
42.
Fausto Biancari Giovanni Mariscalco Magnus Dalén Nicla Settembre Henryk Welp Andrea Perrotti Karsten Wiebe Enrico Leo Antonio Loforte Sidney Chocron Davide Pacini Tatu Juvonen L. Mikael Broman Dario Di Perna Hakeem Yusuff Chris Harvey Nicolas Mongardon Juan P. Maureira Antonio Fiore 《Journal of cardiothoracic and vascular anesthesia》2021,35(7):1999-2006
43.
44.
45.
46.
Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohorts 总被引:3,自引:0,他引:3
Oscar Cirioni Andrea Giacometti Davide Drenaggi Fausto Ancarani Giorgio Scalise 《European journal of epidemiology》1999,15(4):387-391
The pathogenicity of Blastocystis hominis is extensively debated in the medical literature. Therefore, we did a prevalence study to investigate the association between the presence of several intestinal parasites and gastrointestinal symptoms in diverse patient cohorts. The study population consisted of 1216 adults, including immunocompromised patients, institutionalized psychiatric or elder subjects, immigrants from developing countries, travellers to developing tropical countries and controls. Several variables for each risk group were considered. Stools specimens, collected in triplicate, were processed by the same technicians. Clinical data about each subject were provided by standardized questionnaires. The presence of gastrointestinal symptoms were related to the presence of any parasite. In addition, on the basis of microbiological results, five subgroups of subjects were evaluated. The results showed a high prevalence of parasites in all the risk groups. Immunocompromised status, recent arrival from developing countries and the presence of behavioural aberrations were significantly related to presence of parasites. B. hominis was the parasite most frequently detected in each studied group. B. hominis showed a significant correlation with gastrointestinal symptoms only when detected in the group including subjects with a severe immunodepression. Immunodepression seems to be a factor of primary importance of the pathogenic role of B. hominis. 相似文献
47.
T M Williams J M Bergman K Brashear M J Breslin C J Dinsmore J H Hutchinson S C MacTough C A Stump D D Wei C B Zartman M J Bogusky J C Culberson C Buser-Doepner J Davide I B Greenberg K A Hamilton K S Koblan N E Kohl D Liu R B Lobell S D Mosser T J O'Neill E Rands M D Schaber J R Huff 《Journal of medicinal chemistry》1999,42(19):3779-3784
48.
Marzena Karcz-Kubicha Katerina Antoniou Anton Terasmaa Davide Quarta Marcello Solinas Zuzana Justinova Antonella Pezzola Rosaria Reggio Christa E Müller Kjell Fuxe Steven R Goldberg Patrizia Popoli Sergi Ferré 《Neuropsychopharmacology》2003,28(7):1281-1291
The involvement of adenosine A(1) and A(2A) receptors in the motor effects of caffeine is still a matter of debate. In the present study, counteraction of the motor-depressant effects of the selective A(1) receptor agonist CPA and the A(2A) receptor agonist CGS 21680 by caffeine, the selective A(1) receptor antagonist CPT, and the A(2A) receptor antagonist MSX-3 was compared. CPT and MSX-3 produced motor activation at the same doses that selectively counteracted motor depression induced by CPA and CGS 21680, respectively. Caffeine also counteracted motor depression induced by CPA and CGS 21680 at doses that produced motor activation. However, caffeine was less effective than CPT at counteracting CPA and even less effective than MSX-3 at counteracting CGS 21680. On the other hand, when administered alone in habituated animals, caffeine produced stronger motor activation than CPT or MSX-3. An additive effect on motor activation was obtained when CPT and MSX-3 were coadministered. Altogether, these results suggest that the motor-activating effects of acutely administered caffeine in rats involve the central blockade of both A(1) and A(2A) receptors. Chronic exposure to caffeine in the drinking water (1.0 mg/ml) resulted in tolerance to the motor effects of an acute administration of caffeine, lack of tolerance to amphetamine, apparent tolerance to MSX-3 (shift to the left of its 'bell-shaped' dose-response curve), and true cross-tolerance to CPT. The present results suggest that development of tolerance to the effects of A(1) receptor blockade might be mostly responsible for the tolerance to the motor-activating effects of caffeine and that the residual motor-activating effects of caffeine in tolerant individuals might be mostly because of A(2A) receptor blockade. 相似文献
49.
50.
Melina Verso Giancarlo Agnelli Sergio Bertoglio Franco C Di Somma Francesco Paoletti Walter Ageno Mario Bazzan Pasquale Parise Roberto Quintavalla Emanuele Naglieri Armando Santoro Davide Imberti Mariella Sorarù Stefano Mosca 《Journal of clinical oncology》2005,23(18):4057-4062
PURPOSE: The extent of venous thromboembolism (VTE) associated with central vein catheters (CVC) in cancer patients remains unclear. The aim of this study was to evaluate the efficacy and safety of the low molecular weight heparin, enoxaparin, in the prevention of VTE. PATIENTS AND METHODS: In a multicenter, double-blind study, consecutive cancer patients scheduled for CVC insertion were randomly assigned to receive either subcutaneous enoxaparin 40 mg once a day or placebo. Treatment was started 2 hours before CVC insertion and continued for 6 weeks. The primary end points of the study were deep vein thrombosis (DVT), confirmed by venography of the CVC limb performed 6 weeks after randomization, or clinically overt pulmonary embolism, confirmed by objective testing during the study drug administration. Patients were assessed for bleeding complications. RESULTS: Three hundred eighty-five patients were randomized, of which 321 (83.4%) underwent venography. A venography was adequate for adjudication in 155 patients in each treatment group. A DVT was observed in 22 patients (14.1%) treated with enoxaparin and in 28 patients (18.0%) treated with placebo, corresponding to a relative risk of 0.78 (95% CI, 0.47 to 1.31). No major bleeding occurred. Five patients (2.6%) in the enoxaparin group and two patients (1.0%) in the placebo group died during the treatment period. CONCLUSION: In this study, no difference in the rate of CVC-related VTE was detected between patients receiving enoxaparin and patients receiving placebo. The dose of enoxaparin used in this study proved to be safe. Clinical trials evaluating higher enoxaparin doses could optimize the efficacy of this agent for this indication. 相似文献